Standard
Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. / Fehse, F.; Trautmann, M.; Holst, J.J.; Halseth, A.E.; Nanyakkara, N.; Nielsen, L.; Fineman, M.S.D.; Kim, D.D.; Nauck, M.A.
In:
J. Clin. Endocrinol. Metab., No. 90, 2005, p. 5991-5997.
Research output: Contribution to journal › Journal article › Research
Harvard
Fehse, F, Trautmann, M, Holst, JJ, Halseth, AE, Nanyakkara, N, Nielsen, L, Fineman, MSD, Kim, DD & Nauck, MA 2005, 'Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes', J. Clin. Endocrinol. Metab., no. 90, pp. 5991-5997.
APA
Fehse, F., Trautmann, M., Holst, J. J., Halseth, A. E., Nanyakkara, N., Nielsen, L., Fineman, M. S. D., Kim, D. D., & Nauck, M. A. (2005). Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab., (90), 5991-5997.
Vancouver
Fehse F, Trautmann M, Holst JJ, Halseth AE, Nanyakkara N, Nielsen L et al. Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 2005;(90):5991-5997.
Author
Fehse, F. ; Trautmann, M. ; Holst, J.J. ; Halseth, A.E. ; Nanyakkara, N. ; Nielsen, L. ; Fineman, M.S.D. ; Kim, D.D. ; Nauck, M.A. / Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. In: J. Clin. Endocrinol. Metab. 2005 ; No. 90. pp. 5991-5997.
Bibtex
@article{74e4eac06c3811dcbee902004c4f4f50,
title = "Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes",
author = "F. Fehse and M. Trautmann and J.J. Holst and A.E. Halseth and N. Nanyakkara and L. Nielsen and M.S.D. Fineman and D.D. Kim and M.A. Nauck",
year = "2005",
language = "English",
pages = "5991--5997",
journal = "J. Clin. Endocrinol. Metab.",
number = "90",
}
RIS
TY - JOUR
T1 - Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes
AU - Fehse, F.
AU - Trautmann, M.
AU - Holst, J.J.
AU - Halseth, A.E.
AU - Nanyakkara, N.
AU - Nielsen, L.
AU - Fineman, M.S.D.
AU - Kim, D.D.
AU - Nauck, M.A.
PY - 2005
Y1 - 2005
M3 - Journal article
SP - 5991
EP - 5997
JO - J. Clin. Endocrinol. Metab.
JF - J. Clin. Endocrinol. Metab.
IS - 90
ER -